exenatide vs tirzepatide Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond Is There Snake Venom in

Diabetes Obes Metab 21(10):22742283

KPV has achieved meaningful NF-kB suppression

Common side effects during the adjustment period (typically the first 24 weeks): Mild nausea usually less intense than when first starting a GLP-1 medication Changes in appetite (some patients notice less appetite suppression early on at the starting 0.25 mg dose) Mild stomach discomfort, bloating, or constipation Injection site reactions Side effects that are less likely during the switch (compared to first-time GLP-1 use), but still possible: Significant vomiting less common given prior GLP-1 exposure, but possible Hypoglycemia particularly relevant for type 2 diabetes patients on insulin or sulfonylureas

This evaluation may include: Detailed medication review to identify potential drug interactions or recent additions Clinical examination to characterise the rash and assess severity Investigation of alternative causes including infections, allergies, or dermatological conditions Review of diabetes control , as poor glycaemic management can predispose to skin problems If the rash is determined to be related to Rybelsus, your doctor may consider dose adjustment, temporary discontinuation, or switching to an alternative diabetes medication